Hitting cancer with high-intensity ultrasound, immunotherapy

In a new study, researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.

https://www.sciencedaily.com/releases/2017/03/170323183132.htm

Source: ScienceDaily Headlines - March 23, 2017 Category: Science Source Type: news